Placenta Diseases

4

Review clinical trials related to Placenta Diseases. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Characterization of Placental Diffusion

DW-MRI Allows a quantitative comparison of diffusion as an expression of tissue hypoxia. The investigators aim is to compare changes in placental diffusion in pregnant women with uncontrolled diabetes compared to healthy pregnant women using DW-MRI. The investigators hypothesize that placentas of diabetic mothers will show lower diffusion / perfusion compared to placentas of healthy women.

Participants needed: 40
Trial details
Age: 18-50Biological sex: FemaleType: InterventionalSponsor: Hillel Yaffe Medical CenterUpdated: Dec 24, 2025Locations: 1
Eligibility criteria

Women with PGAM (Pre-gestational diabetes) diagnosed before 20 weeks of pregnanc... [+1]

pregnant women with placental hypoxia disease related in the past [+5]

Status: Recruiting

Effects of Tuberculosis Infection on Development and Function of the Placenta

The goal of this observational study is to understand how tuberculosis (TB) infection impacts the function and development of the placenta, and whether TB infection can contribute to pregnancy-related disorders through effects on the placenta. The main questions it aims to answer are: * Does TB infection affect the structure of the placenta? * Does TB infection affect the function of the placenta? Pregnant women attending delivery clinics in Addis Abeba, Ethiopia, will be enrolled and classified for TB infection using a blood-based test. We will compare the following outcomes between women with TB infection and women without TB infection: * Pathological lesions of the placenta * Gene and protein expression patterns linked to pregnancy-related disorders * Infant outcome at birth and at 6 weeks after birth

Participants needed: 500
Trial details
Age: 18+Biological sex: FemaleType: ObservationalSponsor: Lund UniversityUpdated: Mar 17, 2025Locations: 1
Eligibility criteria

Women admitted for delivery to study sites [+2]

Chronic comorbidities (other than TB, HIV or pregnancy-related disorder) [+1]

Status: Not yet recruiting

Management of Early-onset Fetal Growth Restriction: Angiogenic Factors Versus Feto-placental Doppler

This is a multicentre, open-label, randomized controlled trial. A total of 340 singleton pregnancies with an EFW ≤10th percentile between 26+0 and 31+6 weeks will be recruited and randomly allocated to either the control or the intervention group. In the control group, standard Doppler-based management will be used. In the intervention group, different soluble fms-like tyrosine kinase to placental growth factor ratio (sFlt-1/PlGF) cutoffs will be incorporated to the current protocol to adjust the frequency of ultrasounds and to plan elective delivery.

Participants needed: 340
Trial details
Age: 18+Biological sex: FemaleType: InterventionalSponsor: Hospital Universitari Vall d'Hebron Research InstituteUpdated: Jun 4, 2024Locations: 27
Eligibility criteria

Pregnant women of at least 18 years old [+3]

Major fetal malformations or genetic disorders [+3]

Status: Not yet recruiting

Gestational Diabetes Mellitus: "Placental-maternal Crosstalk and Future Health"

The GaP study is designed to close important knowledge gaps by: 1. exploring placental health and cellular ageing in GDM and the association with neonatal outcome 2. evaluating the effectiveness of current and novel maternal health follow-up strategies after GDM

Participants needed: 350
Trial details
Age: 18+Biological sex: FemaleType: ObservationalSponsor: Oslo University HospitalUpdated: May 23, 2023Locations: 1
Eligibility criteria

Pregnant women >18 years with GDM giving birth at Oslo University hospital Ullev... [+1]

reduced fetal movements, [+8]